Monday 1/26 Insider Buying Report: EGBN, VIVO Monday, January 26, 1:47 PM ET
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Thursday, Eagle Bancorp (EGBN)'s CEO, Ronald D. Paul, made a $328,982 buy of EGBN, purchasing 10,000 shares at a cost of $32.90 a piece. So far Paul is in the green, up about 2.7% on their buy based on today's trading high of $33.79. Eagle Bancorp is trading up about 0.7% on the day Monday. Before this latest buy, Paul made one other buy in the past twelve months, purchasing $319,900 shares at a cost of $31.99 each.
And on Friday, Director Dwight E. Ellingwood purchased $35,126 worth of Meridian Bioscience (VIVO), purchasing 1,980 shares at a cost of $17.74 a piece. Before this latest buy, Ellingwood made one other purchase in the past twelve months, buying $16,083 shares at a cost of $16.08 each. Meridian Bioscience is trading up about 0.3% on the day Monday.
For MarketNewsVideo.com, I'm Sayoko Murase.
|